Abstract
To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment - adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures - was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6-13.9).
Cite
CITATION STYLE
APA
Colson, A. E., Sax, P. E., Keller, M. J., Turk, B. K., Pettus, P. T., Platt, R., & Choo, P. W. (2001). Paronychia in association with indinavir treatment. Clinical Infectious Diseases, 32(1), 140–143. https://doi.org/10.1086/317546
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free